I agree that this site is using cookies. You can find further informations here.
X
Balu-Iyer, Sathy V
90  results:
Search for persons X
?
1

A mechanistic marker-based screening tool to predict clinic..:

Jarvi, Nicole L. ; Balu-Iyer, Sathy V.
Communications Medicine.  3 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
2

Phosphatidylserine-mediated oral tolerance:

Nguyen, Nhan H. ; Chak, Vincent ; Keller, Katherine..
Cellular Immunology.  384 (2023)  - p. 104660 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Immunogenicity of Therapeutic Biological Modalities - Lesso..:

Nguyen, Nhan H. ; Jarvi, Nicole L. ; Balu-Iyer, Sathy V.
Journal of Pharmaceutical Sciences.  112 (2023)  9 - p. 2347-2370 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Biophysical Characterization of Tolerogenic Lipid-Based Nan..:

Nguyen, Nhan H. ; Chen, Manlin ; Chak, Vincent.
Journal of Pharmaceutical Sciences.  111 (2022)  7 - p. 2072-2082 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Novel phosphatidylserine-binding molecule enhances antitumo..:

Bhatta, Maulasri ; Shenoy, Gautam N ; Loyall, Jenni L...
Journal for ImmunoTherapy of Cancer.  9 (2021)  10 - p. e003148 , 2021
Link: https://doi.org/10.1136/..
 
?
6

Immunogenicity Challenges Associated with Subcutaneous Deli..:

Jarvi, Nicole L. ; Balu-Iyer, Sathy V.
BioDrugs.  35 (2021)  2 - p. 125-146 , 2021
Link: https://doi.org/10.1007/..
 
?
7

Rational design of a nanoparticle platform for oral prophyl..:

Nguyen, Nhan H. ; Glassman, Fiona Y. ; Dingman, Robert K....
Scientific Reports.  11 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
8

Immunogenicity of Protein Pharmaceuticals:

Dingman, Robert ; Balu-Iyer, Sathy V.
Journal of Pharmaceutical Sciences.  108 (2019)  5 - p. 1637-1654 , 2019
Link: https://doi.org/10.1016/..
 
?
9

Subcutaneous administration of Lyso-phosphatidylserine nano..:

Glassman, Fiona Y. ; Balu-Iyer, Sathy V.
International Journal of Pharmaceutics.  548 (2018)  1 - p. 642-648 , 2018
Link: https://doi.org/10.1016/..
 
?
10

Lipidic Nanoparticles Comprising Phosphatidylinositol Mitig..:

Schneider, Jennifer L. ; Dingman, Robert K. ; Balu-Iyer, Sathy V.
Journal of Pharmaceutical Sciences.  107 (2018)  3 - p. 831-837 , 2018
Link: https://doi.org/10.1016/..
 
?
11

Challenges and Opportunities for the Subcutaneous Delivery ..:

Turner, Michael R. ; Balu-Iyer, Sathy V.
Journal of Pharmaceutical Sciences.  107 (2018)  5 - p. 1247-1260 , 2018
Link: https://doi.org/10.1016/..
 
?
12

Phosphatidylserine Is Not Just a Cleanup Crew but Also a We..:

Glassman, Fiona Y. ; Schneider, Jennifer L. ; Ramakrishnan, Radha...
Journal of Pharmaceutical Sciences.  107 (2018)  8 - p. 2048-2054 , 2018
Link: https://doi.org/10.1016/..
 
?
13

Effect of Biophysical Properties of Phosphatidylserine Part..:

Ramakrishnan, Radha ; Balu-Iyer, Sathy V.
Journal of Pharmaceutical Sciences.  105 (2016)  10 - p. 3039-3045 , 2016
Link: https://doi.org/10.1016/..
 
?
14

Phosphatidylserine Converts Immunogenic Recombinant Human A..:

Schneider, Jennifer L. ; Balu-Iyer, Sathy V.
Journal of Pharmaceutical Sciences.  105 (2016)  10 - p. 3097-3104 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Soy Phosphatidylinositol–Containing Lipid Nanoparticle Prol..:

Shetty, Krithika A. ; Merricks, Elizabeth P. ; Raymer, Robin...
Journal of Pharmaceutical Sciences.  105 (2016)  8 - p. 2459-2464 , 2016
Link: https://doi.org/10.1016/..
 
1-15